<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medalphabet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский алфавит</journal-title><trans-title-group xml:lang="en"><trans-title>Medical alphabet</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2078-5631</issn><issn pub-type="epub">2949-2807</issn><publisher><publisher-name>ООО «Альфмед»</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">medalphabet-513</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group></article-categories><title-group><article-title>Изучение генетических полиморфизмов у больных с факторами риска сердечно-сосудистых заболеваний</article-title><trans-title-group xml:lang="en"><trans-title>Study of genetic polymorphisms in patients with cardiovascular disease risk factors</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чукаева</surname><given-names>И. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Chukaeva</surname><given-names>I. I.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Орлова</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Orlova</surname><given-names>N. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Горяйнова</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Goryainova</surname><given-names>S. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Спирякина</surname><given-names>Я. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Spiryakina</surname><given-names>Ya. G.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Наседкина</surname><given-names>Т. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Nasedkina</surname><given-names>T. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Архипова</surname><given-names>В. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Arkhipova</surname><given-names>V. S.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Козина</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kozina</surname><given-names>A. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Российский национальный исследовательский медицинский университет имени Н. И. Пирогова» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Russian National Research Medical University n.a. N. I. Pirogov</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБУН «Институт молекулярной биологии имени В. А. Энгельгардта» Российской академии наук</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Institute of Molecular Biology n.a. V. A. Engelhardt, City Clinical</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ГБУЗ г. Москвы «Городская клиническая больница № 13» Департамента здравоохранения г. Москвы</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Hospital № 13</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>28</day><month>01</month><year>2018</year></pub-date><volume>1</volume><issue>3</issue><issue-title>Артериальная гипертензия</issue-title><fpage>6</fpage><lpage>10</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Чукаева И.И., Орлова Н.В., Горяйнова С.В., Спирякина Я.Г., Наседкина Т.В., Архипова В.С., Козина А.А., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Чукаева И.И., Орлова Н.В., Горяйнова С.В., Спирякина Я.Г., Наседкина Т.В., Архипова В.С., Козина А.А.</copyright-holder><copyright-holder xml:lang="en">Chukaeva I.I., Orlova N.V., Goryainova S.V., Spiryakina Y.G., Nasedkina T.V., Arkhipova V.S., Kozina A.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-alphabet.com/jour/article/view/513">https://www.med-alphabet.com/jour/article/view/513</self-uri><abstract><p>Сердечно-сосудистые заболевания являются социально значимыми. В патогенез развития заболеваний большая роль отводится факторам риска, развитию воспаления и наследственной предрасположенности. В исследовании изучены ассоциации полиморфизмов генов АРОА1, АРОЕ, ACE, REN, AGT, AGTR 1, AGTR 2, BDKRB 2, MTHFR, ADRB 2,1RS, И-10 и TNF-a с факторами риска развития сердечно-сосудистых заболеваний: ожирение, сахарный диабет II типа, дислипидемия. Изучена ассоциация генов системы воспаления с факторами риска. Результаты исследования выявили перекрестную ассоциацию полиморфизмов генов с факторами риска, а также взаимосвязь всех факторов риска с генами системы воспаления.</p></abstract><trans-abstract xml:lang="en"><p>Cardiovascular diseases are socially imporfanf. A major role in fheir pafhogenesis is assigned fo risk facfors, inflammation and heredifary predisposifion. Associafions of polymorphisms of fhe genes AROA1, APOE, ACE, REN, AGT, AGTR 1, AGTR 2, BDKRB 2, MTHFR, ADRB 2, IRS, IL-10 and TNF-a wifh cardiovascular diseases risk facfors: obesify, diabefes melifus, dyslipidemia, have been sfudied. The associafion of fhe genes of fhe inflammafory sysfem wifh risk facfors also has been sfudied. The resulfs of fhe sfudy revealed a cross-associafion of gene polymorphisms wifh risk facfors, as well as fhe inferrelafion of all risk facfors wifh fhe genes of fhe inflammafory sysfem.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>ИБС</kwd><kwd>факторы риска</kwd><kwd>дислипидемия</kwd><kwd>сахарный диабет</kwd><kwd>ожирение</kwd><kwd>полиморфизм</kwd><kwd>ген АРОА1</kwd><kwd>ген АРОЕ</kwd><kwd>ген ACE</kwd><kwd>ген REN</kwd><kwd>ген AGT</kwd><kwd>ген AGTR1</kwd><kwd>ген AGTR 2</kwd><kwd>ген BDKRB 2</kwd><kwd>ген MTHFR</kwd><kwd>ген ADRB 2</kwd><kwd>ген 1RS</kwd><kwd>ген IL-10</kwd><kwd>ген TNF-a</kwd></kwd-group><kwd-group xml:lang="en"><kwd>IHD</kwd><kwd>risk facfors</kwd><kwd>dyslipidemia</kwd><kwd>diabefes melifus</kwd><kwd>obesify</kwd><kwd>polymorphism</kwd><kwd>ADOA1 gene</kwd><kwd>APOE gene</kwd><kwd>ACE gene</kwd><kwd>REN gene</kwd><kwd>AGT gene</kwd><kwd>AGTR 1 gene</kwd><kwd>AGTR 2 gene</kwd><kwd>BDKRB 2 gene</kwd><kwd>MTHFR gene</kwd><kwd>ADRB 2 gene</kwd><kwd>IRS gene</kwd><kwd>IL-10</kwd><kwd>fhe TNF-a gene</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Piepoli M. F., Hoes A. W., Agewall S., Albus C., Brofons C. et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. European Heart Journal. 2016; 37: 2315-2381.</mixed-citation><mixed-citation xml:lang="en">Piepoli M. F., Hoes A. W., Agewall S., Albus C., Brofons C. et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. European Heart Journal. 2016; 37: 2315-2381.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Lee S. C., Pu Y. B., Thomas G. N. Tumor necrosis factor alpha gene G-308A polymorphism in the metabolic syndrome. Metabolism. 2000; 49 (8): 1021-1024.</mixed-citation><mixed-citation xml:lang="en">Lee S. C., Pu Y. B., Thomas G. N. Tumor necrosis factor alpha gene G-308A polymorphism in the metabolic syndrome. Metabolism. 2000; 49 (8): 1021-1024.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Орлова Н. В. Генетическая обусловленность воспаления при атеросклеротическом поражении сосудов сердца. Сердечная недостаточность. 2008; 9 (4): 180-3.</mixed-citation><mixed-citation xml:lang="en">Орлова Н. В. Генетическая обусловленность воспаления при атеросклеротическом поражении сосудов сердца. Сердечная недостаточность. 2008; 9 (4): 180-3.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Keso Т., Perola М., Laippala Р. et al. Polymorphisms within the tumor necrosis factor locus and prevalence of coronary artery disease in middle-aged men. Atherosclerosis. 2001; 154:691-7.</mixed-citation><mixed-citation xml:lang="en">Keso Т., Perola М., Laippala Р. et al. Polymorphisms within the tumor necrosis factor locus and prevalence of coronary artery disease in middle-aged men. Atherosclerosis. 2001; 154:691-7.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Чукаева И. И., Орлова Н. В., Алешкин В. А., Пухальский А. Л. Воспалительные реакции у больных ишемической болезнью сердца с сопутствующими ожирением и сахарным диабетом 2 типа. Клиническая медицина. 2008; 1: 27-30.</mixed-citation><mixed-citation xml:lang="en">Чукаева И. И., Орлова Н. В., Алешкин В. А., Пухальский А. Л. Воспалительные реакции у больных ишемической болезнью сердца с сопутствующими ожирением и сахарным диабетом 2 типа. Клиническая медицина. 2008; 1: 27-30.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Bautista L. E., Veram L. M., Arenas I. A., Gamarra G. Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-a) and essential hypertension. J. Hum. Hypertension. 2005; 19: 149-154.</mixed-citation><mixed-citation xml:lang="en">Bautista L. E., Veram L. M., Arenas I. A., Gamarra G. Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-a) and essential hypertension. J. Hum. Hypertension. 2005; 19: 149-154.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Скибицкий В. В. Факторы риска и структура кардиоваскулярной патологии у женщин в климаксе различного генеза. Про-блемаженского здоровья. 2007; 3 (2): 21-28.</mixed-citation><mixed-citation xml:lang="en">Скибицкий В. В. Факторы риска и структура кардиоваскулярной патологии у женщин в климаксе различного генеза. Про-блемаженского здоровья. 2007; 3 (2): 21-28.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Sambrook, J., Fritsch, E.F., and Maniatis, T. Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY,1989.</mixed-citation><mixed-citation xml:lang="en">Sambrook, J., Fritsch, E.F., and Maniatis, T. Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY,1989.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Shoulders C. C., Jones E. L., Naoumo-va R. P. Genetics of familial combined hyper-lipidemia and risk of coronary heart disease. Human. Molecular Genetics. 2004; 13: 149-160.</mixed-citation><mixed-citation xml:lang="en">Shoulders C. C., Jones E. L., Naoumo-va R. P. Genetics of familial combined hyper-lipidemia and risk of coronary heart disease. Human. Molecular Genetics. 2004; 13: 149-160.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Hribal M. L., Federici M., Porzio O. The Gl-yArg972 amino acid polimorphism in IRS-1 affects glucose metabolism in skeletal muscle cells. J. Clin.Endocrinol. Metab. 2000; 85: 2004-2013.</mixed-citation><mixed-citation xml:lang="en">Hribal M. L., Federici M., Porzio O. The Gl-yArg972 amino acid polimorphism in IRS-1 affects glucose metabolism in skeletal muscle cells. J. Clin.Endocrinol. Metab. 2000; 85: 2004-2013.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">França E., Alves J. G.B., Hutz M. H. APOA1/C3/A4 gene cluster variability and lipid levels in Brazilian children. Braz. J. Med. Biol. Res. 2005; 38 (04): 535-541.</mixed-citation><mixed-citation xml:lang="en">França E., Alves J. G.B., Hutz M. H. APOA1/C3/A4 gene cluster variability and lipid levels in Brazilian children. Braz. J. Med. Biol. Res. 2005; 38 (04): 535-541.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Garasto S., Rose G., Derango F. The Study of APOA1, APOC3 and APOA4 Variability in Healthy Ageing People Reveals Another Paradox in the Oldest Old Subjects. Annals of Human Genetics. 2003; 67: P. 54</mixed-citation><mixed-citation xml:lang="en">Garasto S., Rose G., Derango F. The Study of APOA1, APOC3 and APOA4 Variability in Healthy Ageing People Reveals Another Paradox in the Oldest Old Subjects. Annals of Human Genetics. 2003; 67: P. 54</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
